Timely delivery: Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug

Aug 06, 2012
Timely delivery: Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug

(Phys.org) -- Many drug candidates fail because of low solubility or poor pharmacokinetic behavior. Ron Raines and colleagues at the University of Wisconsin–Madison (USA) have devised a new prodrug strategy to overcome these limitations. Their approach takes advantage of the capacity of an enzyme prevalent in human serum–pancreatic-type ribonuclease—to catalyze the cleavage of a drug conjugated to a ribonucleoside 3'-phosphate; the results of their work are reported in ChemMedChem.

They demonstrated efficacy by using metronidazole, a sparingly soluble antibiotic that is often administered orally. In the absence of ribonuclease, metronidazole conjugates are stable and inactive. Physiological levels of enzyme render the conjugate toxic to Bacteroides fragilis, a common penicillin-resistant bacillus that is responsible for anaerobic infections. Alterations to the ribonucleoside enable modulation of key attributes, such as the rate of drug delivery.

This study paves the way for further research into the activation and timed release of drugs of varying aqueous .

Explore further: Engineering a protein to prevent brain damage from toxic agents

More information: Ronald T. Raines, Ribonucleoside 3'-Phosphates as Pro-Moieties for an Orally Administered Drug, ChemMedChem 2012, 7, No. 8, dx.doi.org/10.1002/cmdc.201200243

add to favorites email to friend print save as pdf

Related Stories

Researchers make neurological disease breakthrough

Oct 07, 2011

(Medical Xpress) -- Results of a study by a group of University of Notre Dame researchers represent a promising step on the road to developing new drugs for a variety of neurological diseases.

Research team gives drug dropouts a second chance

May 07, 2012

(Phys.org) -- A cross-disciplinary team of researchers at the University of Maryland has designed a molecular container that can hold drug molecules and increase their solubility, in one case up to nearly ...

Recommended for you

Two teams pave way for advances in 2D materials

2 hours ago

This month's headlines on two-dimensional polymers showed noteworthy headway. "2-D Polymer Crystals Confirmed At Last," said Chemical & Engineering News. "Engineers Make the World's First Verified, 2-Dimensional P ...

Nature inspires a greener way to make colorful plastics

21 hours ago

Long before humans figured out how to create colors, nature had already perfected the process—think stunning, bright butterfly wings of many different hues, for example. Now scientists are tapping into ...

New catalyst converts carbon dioxide to fuel

23 hours ago

Scientists from the University of Illinois at Chicago have synthesized a catalyst that improves their system for converting waste carbon dioxide into syngas, a precursor of gasoline and other energy-rich products, bringing ...

Bullet 'fingerprints' to help solve crimes

23 hours ago

Criminals don't just have to worry about their own fingerprints these days: because of a young forensic scientist at The University of Western Australia, they should also be very concerned about their bullets' ...

User comments : 0